Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Diagnostics Laboratory, |
RCV000760161 | SCV000889978 | pathogenic | Nystagmus 6, congenital, X-linked | 2017-04-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002533136 | SCV002955233 | pathogenic | not provided | 2023-11-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile244Thrfs*10) in the GPR143 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GPR143 are known to be pathogenic (PMID: 15965158, 18978956, 19390656, 21541274, 26160353, 28211458). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with GPR143-related conditions. ClinVar contains an entry for this variant (Variation ID: 619966). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV002533136 | SCV003803348 | pathogenic | not provided | 2023-02-10 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 18978956, 28211458, 26160353, 15965158, 21541274, 19390656) |